NYT director receives 54 dividend RSUs
Brooke Beth A. reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Brooke Beth A. reported acquisition or exercise transactions in this Form 4 filing.
New York Times Company director Beth A. Brooke received an award of 54 shares of Class A Common Stock on a grant basis, with no purchase price. These shares are Restricted Stock Units granted as dividend equivalents on previously awarded RSUs under the company’s 2020 Incentive Compensation Plan.
Dividend Equivalent RSUs tied to vested RSUs are fully vested at grant, while those tied to unvested RSUs will vest on the same date the underlying RSUs vest, at the first annual meeting following the initial grant. After this award, Brooke directly holds 19,822 Class A shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 54 | $0.00 | $0.00 |
Footnotes (1)
- F1. Restricted Stock Units ("RSUs") acquired in respect of previously reported RSUs awarded under The New York Times Company 2020 Incentive Compensation Plan in connection with, and with a value equal to, cash dividends paid on The New York Times Company's Class A Common Stock ("Dividend Equivalent RSUs"). Dividend Equivalent RSUs granted in respect of vested RSUs are fully vested at grant. Dividend Equivalent RSUs granted in respect of unvested RSUs will vest on the date that such unvested RSUs vest, which is the date of the Company's first annual meeting following the initial grant.
Key Figures
Key Terms
Restricted Stock Units ("RSUs") financial
Dividend Equivalent RSUs financial
2020 Incentive Compensation Plan financial
Class A Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Beth A. Brooke report at NEW YORK TIMES CO (NYT)?
What are Dividend Equivalent RSUs in the context of NEW YORK TIMES CO (NYT)?
How do the vesting terms work for the Dividend Equivalent RSUs reported by NYT director Beth A. Brooke?
Is Beth A. Brooke’s NYT Form 4 transaction a buy or sell signal for investors?
AI-generated analysis. How Rhea-AI works. Not financial advice.